1
40
1
-
Text
A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.
Citation List Month
Backlog
URL Address
<a href="http://doi.org/10.1542/peds.110.1.181" target="_blank" rel="noreferrer">http://doi.org/10.1542/peds.110.1.181</a>
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Uses of drugs not described in the package insert (off-label uses)
Publisher
An entity responsible for making the resource available
Pediatrics
Date
A point or period of time associated with an event in the lifecycle of the resource
2002
Subject
The topic of the resource
Child; Humans; United States; United States Food and Drug Administration; Prescriptions; Organizational Policy; Drug; Clodronate; Drug Approval; Societies; Adverse Drug Reaction Reporting Systems/legislation & jurisprudence; Drug Labeling/legislation & jurisprudence; Internet/legislation & jurisprudence; Medical/standards; Pediatrics/legislation & jurisprudence/standards; Physician's Practice Patterns/legislation & jurisprudence
Creator
An entity primarily responsible for making the resource
Committee on Drugs - American Academy of Pediatrics
Description
An account of the resource
New regulatory initiatives have been designed to ensure that new drugs and biologicals include adequate pediatric labeling for the claimed indications at the time of, or soon after, approval. However, because such labeling may not immediately be available, off-label use (or use that is not included in the approved label) of therapeutic agents is likely to remain common in the practice of pediatrics. This policy statement was written to address questions practitioners have regarding off-label use. The purpose of off-label use is to benefit the individual patient. Practitioners may use their professional judgment to determine these uses. Practitioners should understand that the Food and Drug Administration does not regulate off-label use.
2002
Identifier
An unambiguous reference to the resource within a given context
<a href="http://doi.org/10.1542/peds.110.1.181" target="_blank" rel="noreferrer">10.1542/peds.110.1.181</a>
Rights
Information about rights held in and over the resource
Article information provided for research and reference use only. PedPalASCNET does not hold any rights over the resource listed here. All rights are retained by the journal listed under publisher and/or the creator(s).
Type
The nature or genre of the resource
Journal Article
2002
Adverse Drug Reaction Reporting Systems/legislation & jurisprudence
Backlog
Child
Clodronate
Committee on Drugs - American Academy of Pediatrics
Drug
Drug Approval
Drug Labeling/legislation & jurisprudence
Humans
Internet/legislation & jurisprudence
Journal Article
Medical/standards
Organizational Policy
Pediatrics
Pediatrics/legislation & jurisprudence/standards
Physician's Practice Patterns/legislation & jurisprudence
Prescriptions
Societies
United States
United States Food and Drug Administration